Attempted prophylaxis of human immunodeficiency virus type 1 infection in chimpanzees with a nonnucleoside reverse transcriptase inhibitor.
Schleif
W A
WA
Merck Research Laboratories, West Point, Pennsylvania 19486.
Murthy
K K
KK
Sardana
V V
VV
Schneider
C L
CL
Byrnes
V W
VW
Cobb
K E
KE
Roth
E
E
Wolfgang
J A
JA
Hoffman
J M
JM
Smith
A M
AM
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D001583:Benzoxazoles / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D015658:HIV Infections / Q000517:prevention & control*; D054303:HIV Reverse Transcriptase; D002679:Pan troglodytes; D011728:Pyridones / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors
D000998:Antiviral Agents; D001583:Benzoxazoles; D011728:Pyridones; D018894:Reverse Transcriptase Inhibitors; C076250:L 696229; D054303:HIV Reverse Transcriptase